VSIG8 (Val22-Gly263)_x000D_ Accession # P0DPA2 | His |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3800 |
PODXL2 (Gly33-Thr500)_x000D_ Accession # Q9NZ53 | His |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥2600 |
hFc | GITR Ligand/TNFSF18 (Thr47-Ser173)_x000D_ Accession # Q7TS55 |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3100 |
HPX (Ser24-Gln460)_x000D_ Accession # Q91X72 | His |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3000 |
CTGF/CCN2 (Gln27-Ala349)_x000D_ Accession # H9FQD5 | His |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3500 |
MASP2 (Gly288-Phe686)_x000D_ Accession # O00187-1 | His |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥4500 |
IGFBP-7 (Ser27-Leu282) Accession # Q16270 | hFc |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3500 |
HLA-E*01:03&B2M&Peptide (VMAPKTLVL) Monomer Negative Control[Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M) and VMAPKTLVL peptide] Accession # P13747(HLA-E*01:03)&P61769(B2M)&VMAPKTLVL | His | Avi |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3000 |
IGFBP-7 (Ser26-Leu281)_x000D_ Accession # Q61581 | hFc |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥3500 |
IGFBP-3 (Gly28-Lys291) Accession # AAH18962 | His |
N-term | C-term |
规格 | 价 格(¥) | 数量 | |
¥2200 |